Related Experiment Video
Updated: Jun 13, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
OPTN/SRTR 2024 Annual Data Report: Heart
Monica M Colvin1, Jodi M Smith2, Colin T Stomberski1
1Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN; Department of Cardiology, University of Michigan, Ann Arbor, MI.
Insights
Heart transplant numbers in the US surged in 2024, yet demand outpaces supply, especially for pediatric patients. Survival rates remain stable, but transplant rates have declined for most pediatric age groups.
Area of Science:
- Cardiology and Transplant Surgery
- Public Health and Healthcare Trends
- Medical Statistics and Outcomes Research
Background:
- Heart transplantation is a critical treatment for end-stage heart failure.
- Significant increases in heart transplant volume have been observed, but demand continues to exceed supply.
- Trends in adult and pediatric heart transplantation require ongoing analysis to understand patient outcomes and resource allocation.
Purpose of the Study:
- To analyze the trends in heart transplantation in the United States in 2024 compared to 2013.
- To evaluate changes in heart transplant rates across different age groups, particularly pediatric recipients.
- To assess pretransplant mortality, donor characteristics, and post-transplant survival rates.
Main Methods:
- Analysis of national heart transplant data from 2013 and 2024.
- Comparison of transplant volumes, waiting list numbers, and new listings for adult and pediatric patients.
- Examination of transplant rates per 100 patient-years, pretransplant mortality, and survival outcomes based on recipient status and support devices.
Main Results:
- Total US heart transplants reached a record 4,636 in 2024, an 81.5% increase since 2013, but demand remains unmet.
- Pediatric heart transplant rates have declined since 2013, with significant decreases in younger age groups.
- Pretransplant mortality decreased to 8.4 deaths/100 patient-years in adults and a 10-year low of 8.2 in pediatric candidates; 1- and 5-year survival rates remained stable.
Conclusions:
- Despite record transplant volumes, the gap between heart transplant supply and demand persists, particularly for pediatric candidates.
- Declining transplant rates in most pediatric age groups warrant further investigation into underlying causes.
- Stable post-transplant survival rates highlight the continued efficacy of heart transplantation, though recipient listing status impacts outcomes.
Abstract:
In 2024, the total number of heart transplants in the United States reached a record of 4,636, an 81.5% increase since 2013. Of these, 4,146 occurred in adults while 490 occurred in pediatric recipients (93.5% and 19.2% increases, respectively, since 2013). This growth has been insufficient to meet the demand, as the number of adult patients awaiting transplant has always far exceeded the number of transplants performed. This is compounded by increasing numbers of new listings, although new adult listings have increased to a lesser extent (by 57.0%) than adult transplants since 2013. Pediatric heart transplants have only increased 19.2% since 2013, with an apparent plateau since 2018. Except for pediatric candidates aged 12-17 years and those who turned 18 while waiting, there has been a decline in heart transplant rates since 2013: in candidates younger than 1 year, a 48.2% decrease (123.6 [in 2024] versus 238.5 [in 2013] transplants per 100 patient-years); in those aged 1-5 years, a 41.4% decrease (54.0 versus 92.1 transplants per 100 patient-years); and in those aged 6-11 years, an 18.2% decrease (71.0 versus 86.8 transplants per 100 patient-years). The prevalence of heart donors after circulatory death increased to 17.9%. Pretransplant mortality in adults declined slightly, to 8.4 deaths per 100 patient-years, and in pediatric candidates reached a 10-year low of 8.2 deaths per 100 patient-years. Most adult heart transplants (54.9%) were performed at adult status 2, while most pediatric heart transplants (88.8%) were performed at status 1A. There were 974 transplants performed in adults with Impella only, 716 with intra-aortic balloon pump only, and 189 with extracorporeal membrane oxygenation only. The 1- and 5-year survival after transplant remained stable (for transplants in 2017-2019): 91.2% and 80.1% in adults and 92.3% and 83.9% in pediatric recipients, respectively. Two-year survival was lowest in recipients listed at adult status 5 (79.3%) and highest in recipients listed at adult status 6 (91.1%).
Related Concept Videos
Holter Monitor: 24-Hour Monitoring
Data Reporting and Recording
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Heart Failure V: Medical Management